title: [The effectiveness of the pimafucin 100 mg pill for intravaginal treatment of vaginal candidiasis].
abstract: The aim of this multicentre prospective study was assessing the effectiveness of intravaginal treatment of vaginal candidiasis with Pimafucin 100 mg ovule. Success was obtained among 81% pregnant and 86% nonpregnant women. The negative predictive factors were intensive patients complains: pruritus or soreness.
authors.affiliation: Kliniki Połoznictwa i Ginekologii Instytutu Matki i Dziecka w Warszawie.
authors.forename: B
authors.initials: B
authors.lastname: Chazan
authors.forename: E
authors.initials: E
authors.lastname: Filipp
authors.forename: I
authors.initials: I
authors.lastname: Kozak-Darmas
authors.forename: A
authors.initials: A
authors.lastname: Raczyński
authors.forename: E
authors.initials: E
authors.lastname: Swiatek
authors.forename: A
authors.initials: A
authors.lastname: Staszewski
mesh_terms: D000282:Administration, Intravaginal; D000293:Adolescent; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use*; D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010866:Natamycin / Q000627:therapeutic use*; D011237:Predictive Value of Tests; D011247:Pregnancy; D011446:Prospective Studies; D016896:Treatment Outcome
chemical_list: D000935:Antifungal Agents; D010866:Natamycin